For the first time, KIC Ventures has opened a $15M Series A round, offering a rare opportunity for you to invest in owning shares in AxioMed revolutionary viscoelastic disc replacement and NANISX outpatient spine innovations. High potential for significant returns and global impact
Investor Cover letter
KIC Ventures Targets $5 Billion Valuation in 5 Years: Opens Up Series A to Investors
Dear Colleagues, Friends, and Supporters,
You're Invited to Invest in the Future of Spine Surgery
At KIC Ventures, we believe the future of spine care is moving beyond traditional fusion—and we invite you to be part of that transformation.
Our portfolio companies, AxioMed and NANISX, are at the forefront of this shift. Just as cardiology and radiology evolved into interventional specialties, spine surgery is transitioning toward interventional spine care, with a strong focus on motion preservation and Less Exposure Spine Surgery (LESS™).
AxioMed is redefining what’s possible in total disc replacement. Unlike outdated ball-and-socket implants, AxioMed’s viscoelastic lumbar disc is designed to replicate the natural biomechanics of a healthy disc. With FDA approval anticipated in 2025, it stands to become the leading alternative to ProDisc-L.
Meanwhile, NANISX offers a portfolio of LESS™ technologies—Sacrix, Inspan, FacetFuse, and NanoFuse Biologics—that Restore function, Enable early intervention and Preserve anatomy (REP). These solutions are being adopted by a growing number of physicians who seek better patient outcomes with less invasive options.
To support our next phase of growth, including the U.S. launch of AxioMed’s lumbar disc and upcoming cervical and lateral discs, we are raising capital. Over $90 million has been invested to date, and we are now opening a limited investment round to qualified individuals—many of whom invest through IRAs or 401(k)s. Investments have ranged from $50,000 to $2 million.
We also invite interested investors to attend our Visit, Education, and Training (VET) Tour in Florida. This immersive experience provides a firsthand look at our technologies, our team, and our strategic direction. It’s an excellent opportunity to engage directly with our surgeon partners, see our products in action, and understand the long-term vision driving our growth.
If you’d like to explore this opportunity further, we would be happy to share our investor materials and answer any questions you may have.
Thank you for considering joining us in shaping the future of spine care.
Secure your position now. Call Aditya Humad (267-342-3968) or visit www.KICVentures.com.
With gratitude,
The Executive Council | KIC Ventures
self-directed ira (SDIRA) Strategy
Join as a member for a small annual flat fee, and complete a tax-free rollover online of your retirement funds into your SDIRA. For Further Information,
please contact: Mandy@iraclub.com
DISCLAIMER:
This presentation is subject to and conditioned upon the Investor’s (a) reviewing a Confidential Private Placement Memorandum; (b) executing a Subscription Agreement and Investor Questionnaire; (c) being qualified by the Issuer as an Accredited Investor under Regulation D. Investor shall pay no investment funds until all of the foregoing have occurred to the satisfaction of Company as the Issuer. This presentation does not take into account, nor does it provide any tax, legal or investment advice or opinion regarding the specific investment objectives or financial situation of any person. Company reserves the right to amend or replace the information contained herein, in part or entirely, at any time, and undertakes no obligation to notify the recipient thereof.